Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study.
Yenerel MN, Atamer T, Yavuz AS, Kucukkaya R, Besisik S, Aktan M, Keskin H, Nalcaci M, Sargin D, Pekcelen Y, Dincol G.
Ann Hematol. 2002 Sep;81(9):498-503. doi: 10.1007/s00277-002-0524-x. Epub 2002 Sep 6.
PMID:12373349
CD99 in malignant hematopoiesis.
Ali A, Vaikari VP, Alachkar H.
Exp Hematol. 2022 Feb;106:40-46. doi: 10.1016/j.exphem.2021.12.363. Epub 2021 Dec 14.
PMID:34920053
Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J Jr.
Blood. 1990 Jan 1;75(1):198-202.
PMID:2294988
Significance of CD66c expression in childhood acute lymphoblastic leukemia.
Kiyokawa N, Iijima K, Tomita O, Miharu M, Hasegawa D, Kobayashi K, Okita H, Kajiwara M, Shimada H, Inukai T, Makimoto A, Fukushima T, Nanmoku T, Koh K, Manabe A, Kikuchi A, Sugita K, Fujimoto J, Hayashi Y, Ohara A.
Leuk Res. 2014 Jan;38(1):42-8. doi: 10.1016/j.leukres.2013.10.008. Epub 2013 Oct 22.
PMID:24231528
Clinical importance of myeloid antigen expression in Moroccan patients with adult B-lineage acute lymphoblastic leukemia.
Lahjouji A, Bachir F, Bennani S, Benchekroun S, E SA.